Internal Medicine · Villalba, PR
NPI
1952388597
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
149 Road Km 58.0, Sector Tierra Santa
Villalba, PR, 00766
Phone (787) 847-3778
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
29,526 prescriptions
Company payments, 2025
$46.37
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Ana Seda Cordero prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,812 prescriptions and refills. In total Ana Seda Cordero wrote 29,526 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 2,812 | 3,294 | 312 | $18K |
| Losartan Potassium Generic | 1,629 | 1,912 | 186 | $12K |
| Famotidine Generic | 1,558 | 1,597 | 175 | $10K |
| Gabapentin Generic | 1,355 | 1,415 | 144 | $8,929 |
| Metformin Hcl Generic | 1,031 | 1,155 | 114 | $5,034 |
| Amlodipine Besylate Generic | 1,003 | 1,067 | 110 | $3,614 |
| Levothyroxine Sodium Generic | 926 | 981 | 95 | $6,957 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 862 | 1,001 | 97 | $9,080 |
| Tamsulosin Hcl Generic | 709 | 772 | 81 | $4,844 |
| Pantoprazole Sodium Generic | 647 | 670 | 82 | $3,621 |
| Alendronate Sodium Generic | 627 | 660 | 66 | $3,232 |
| Synthroid Levothyroxine Sodium | 626 | 671 | 64 | $31K |
| Metoprolol Succinate Generic | 570 | 610 | 63 | $5,082 |
| Hydrochlorothiazide Generic | 489 | 513 | 57 | $2,113 |
| Simvastatin Generic | 488 | 584 | 62 | $2,358 |
Brand drugs: 4,587 claims; generic drugs: 24,443 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ana Seda Cordero $46.37 ($46.37 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $28.07.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28.07 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $18.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.